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Edited by Varda RotterAbstract Ionizing radiation (IR) is known to upregulate cell
surface Fas through p53 activation in various cells. However,
the signaling pathway intermediating between p53 activation
and cell surface Fas upregulation remains to be elucidated. Re-
cently, Fas-associated phosphatase-1 (FAP-1) has been reported
to associate with Fas and inhibit cell surface Fas expression. We
evaluated the expression of FAP-1 mRNA following IR in A549
cells. Ionizing radiation inhibited the expression of FAP-1
mRNA. Pretreatment with p53 inhibitor piﬁthrin a cancelled
the IR-induced downregulation of FAP-1 mRNA. These results
suggest that IR-induced p53 activation may upregulate cell sur-
face Fas via the down-modulation of FAP-1.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Radiation therapy is an important therapeutic modality in
the treatment of lung cancer. Ionizing radiation (IR) has been
shown to alter phenotype of target tissue, including upregula-
tion of several classes of molecules on tumor cells that could
potentially inﬂuence the susceptibility of the cells to apoptosis
[1]. Of the upregulated molecules, the most characterized is
Fas. Ionizing radiation induces cell surface Fas upregulation
through the activation of p53 [2]. The increase in cell surface
Fas induced by activated p53 involves transcription-dependent
and transcription-independent mechanisms [3,4]. Mu¨ller and
colleagues have demonstrated that induction of Fas gene tran-
scription by p53 is mediated through a strong p53-responsive
element located within the ﬁrst intron of the gene [3]. Bennett
et al. have found that p53 activation can regulate sensitivity to
Fas-mediated apoptosis by allowing cytoplasmic Fas to redis-
tribute to the cell surface [4]. However, the detailed molecularAbbreviations: FAP-1, Fas-associated phosphatase-1; FITC, ﬂuores-
cein isothiocyanate; GAPDH, glyceraldehyde-3-phosphate dehydro-
genase; IR, ionizing radiation; MFI, mean ﬂuorescence intensity;
PFTa, piﬁthrin a
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doi:10.1016/j.febslet.2006.07.003mechanism by which p53 activation increases surface Fas
expression remains uncertain.
Fas-associated phosphatase-1 (FAP-1) is a protein tyrosine
phosphatase, which was identiﬁed as a protein that associates
with Fas [5]. It has been reported that FAP-1 is a negative reg-
ulator of Fas-mediated signal transduction and related to resis-
tance against Fas-mediated apoptosis [6]. Ivanov and
coworkers have shown that FAP-1 association with Fas inhib-
its Fas transport from Golgi complex to the cell surface [7]. Irie
and colleagues have found that there is a potential binding site
of p53 in the FAP-1 promoter, suggesting that activated p53
might suppress the transcription of FAP-1 gene [8].
In this study, using a human adenocarcinoma cell line A549,
we found that IR suppressed the expression of FAP-1 mRNA
via the activation of p53 pathway. Based on the evidence that
FAP-1 inhibits cell surface Fas expression, our ﬁndings indi-
cate that p53 activation following IR induces the upregulation
of Fas on the cell surface through the suppression of FAP-1
expression.2. Materials and methods
2.1. Reagents and antibodies
Piﬁthrin a(PFTa) was purchased from Sigma (Tokyo, Japan). Fluo-
rescein isothiocyanate (FITC)-labeled mouse anti-human Fas mAb,
clone DX2, and FITC-labeled mouse IgG1 were from DAKO JAPAN
Co., Ltd. (Kyoto, Japan). Anti-p53 and anti-p21 antibodies were
obtained from BD Biosciences (San Jose, CA).
2.2. Cell culture
The human adenocarcinoma cell line A549 was purchased from
American Type Culture Collection (Manassas, VA). This cell line
has wild-type p53 [9], and expresses both Fas and FAP-1 [6]. The cul-
ture medium was RPMI 1640 containing 10% heat-inactivated fetal
calf serum, 2 mM L-glutamine, 50 IU/ml penicillin, and 50 lg/ml strep-
tomycin. The cells were grown in 60-mm tissue culture dishes at 37 C
in a 5% CO2 humidiﬁed incubator.
2.3. X-ray irradiation
Reaching 50–70% conﬂuence, cells were irradiated at room temper-
ature with an X-ray source (dose rate: 5 Gy/min; MBR-15020R-3,
Hitachi Medical, Hitachi, Japan).
2.4. Flow cytometric detection of Fas
Suspension of A549 cells (1 · 106 cells) were ﬁxed with 4% parafor-
maldehyde for 15 min at room temperature, and washed twice. The
cells were incubated with FITC-labeled anti-human Fas mAb, DX2,
or FITC-labeled control mouse IgG1, in the dark for 30 min at 4 C.blished by Elsevier B.V. All rights reserved.
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ibur; Becton Dickinson, Mountain View, CA). Ten thousand cells were
examined for each determination. Values for mean ﬂuorescence inten-
sity index (MFI index) were calculated using the formula: MFI
index = [(MFI of anti-Fas Ab-stained cells)  (MFI of control IgG1-
stained cells)]/MFI of control IgG1-stained cells.
2.5. Western blot analysis
The expression of p53 and p21 were determined by immunoblot
analysis. Whole cell lysate extracts were prepared, and the equal
amount of cellular protein (30 lg/well) were separated on SDS–poly-
acrylamide gel (10%) and electrically transferred onto polyvinylidene
ﬂuoride membranes. After blockade of nonspeciﬁc binding, the blots
were revealed by using primary antibodies, the corresponding second-
ary antibodies and ECL detection kit (Amersham Life Science, Tokyo,
Japan).2.6. RT-PCR
Total cellular RNA was extracted, and the ﬁrst strand cDNA was
synthesized using oligo(dT) primer and random primer. PCR was per-
formed on cDNA using primers for the ampliﬁcation of FAP-1 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primers
were designed according to published sequences [10]: FAP-1-sense,Fig. 1. Eﬀect of ionizing radiation on the cell surface expression of Fas in A5
Fas expression. After the indicated doses of irradiation, A549 cells were incu
ﬂow cytometer. (B) Time-dependent eﬀect of ionizing radiation on cell surfa
cultured for the indicated time periods. Cell surface Fas expression was then a
stained with anti-Fas Ab. A dashed line denotes a histogram of cells stained
ﬂuorescence intensity index (MFI index).5 0-GAATACGAGTGTCAGACATGG-30; FAP-1-antisense, 5 0-AGG
TCTGCAGAGAAGCAAGAATAC-30; GAPDH-sense, 5 0-CAAA-
AGGGTCATCATCTCTG-3 0; and GAPDH-antisense, 5 0-CCTGC-
TTCACCACCTTCTTG-30. Thermal cycling for FAP-1 and GAPDH
was carried out as follows: 28 cycles, denaturation at 95 C for 1 min,
annealing at 58 C for 2 min, and extension at 72 C for 1 min. PCR
products were analyzed by electrophoresis through 1.2% agarose gels
and viewed under UV light after ethidium bromide staining.
2.7. Statistical analysis
We repeated each type of experiment at least three times and con-
ﬁrmed that similar data were obtained. All values are means ± S.E.M.
Comparisons were made with one-way ANOVA with Fisher’s post hoc
test. A P value of <0.05 was considered signiﬁcant.3. Results
3.1. Upregulation of cell surface Fas by IR
The initial experiment was performed to determine whether
IR was capable of inducing the upregulation of cell surface Fas
on A549 cells. A549 cells were irradiated and the level of Fas49 cells. (A) Dose-dependent eﬀect of ionizing radiation on cell surface
bated for 12 h, and then cell surface Fas expression was analyzed by a
ce Fas expression. A549 cells were exposed to irradiation (2 Gy) and
nalyzed by a ﬂow cytometer. A solid line represents a histogram of cells
with control mouse IgG1. The number of each panel represents mean
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Fig. 3. Western immunoblot analysis of p53 and p21 in A549 cells. (A)
Time-course of p53 and p21 accumulation after irradiation (2 Gy) in
A549 cells. (B) Eﬀect of p53 inhibitor PFTa on the accumulation of
p21 in irradiated A549 cells. Cells were pretreated with PFTa (50 lM)
for 3 h, and exposed to ionizing radiation (2 Gy). After 3 h, the
accumulation of p53 and p21 was investigated.
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induced dose-dependent and time-dependent increase in cell
surface Fas (Figs. 1A and B).
3.2. Ionizing radiation downregulates the expression of FAP-1
mRNA in A549 cells
It is reported that FAP-1 association with Fas inhibits its ex-
port to the cell surface [7]. Hence, we evaluated the eﬀect of IR
on FAP-1 mRNA expression in A549 cells. The time-course of
FAP-1 mRNA after exposure to IR is shown in Figs. 2A and
B. Ionizing radiation downregulated FAP-1 mRNA expres-
sion. The kinetics of FAP-1 mRNA expression was biphasic
after irradiation, with the ﬁrst trough at 1.5 h and the second
trough at 24 h.
3.3. Piﬁthrin a can inhibit the transcriptional activity of p53
Consistent with the knowledge that IR activates p53 [11,12],
IR caused A549 cells to increase the levels of p53 biphasically,
which seems to represent a mirror image of the time-dependent
kinetics of FAP-1 mRNA (Fig. 3A). A p53 inhibitor PFTa
suppressed the IR-induced accumulation of p21 protein in
A549 cells (Fig. 3B), indicating that PFTa eﬀectively inhibited
the transcriptional activity of p53.
3.4. Involvement p53 in the downregulation of FAP-1 mRNA
induced by IR
Using PFTa, we explored the involvement of p53 in the IR-
induced downregulation of FAP-1 mRNA expression in A549
cells. Pretreatment with PFTa cancelled the suppression of
FAP-1 mRNA expression by IR (Fig. 4). This result clearly0
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Fig. 2. Eﬀect of ionizing radiation on FAP-1 mRNA expression in
A549 cells. (A) Time-course of ionizing radiation-induced FAP-1
mRNA expression in A549 cells. After irradiation (2 Gy), cells were
incubated for the indicated time periods, and then analyzed for FAP-1
mRNA by RT-PCR. (B) The ratio of FAP-1 to GAPDH mRNA was
calculated and expressed relative to that of untreated A549 cells. The
values are means ± S.E.M. of three independent experiments.shows that the level of FAP-1 mRNA expression is negatively
modulated by p53 activity.4. Discussion
In the present study, we have demonstrated that IR increases
the cell surface Fas and suppresses the expression of FAP-1
mRNA via p53 activation in A549 cells. On the basis of the
observations that FAP-1 association with Fas inhibits its ex-
port to the cell surface [7], and that there is a potential binding
site of p53 in the 5 0 ﬂanking region of the human FAP-1 gene
[8], our ﬁndings imply that the downregulation of FAP-1 by
activated p53 may play an important role in the IR-induced
upregulation of cell surface Fas. Our study is the ﬁrst report
on the involvement of p53 activation in FAP-1 mRNA expres-
sion. Although a number of studies have reported that p53 is
involved in the IR-induced cell surface Fas expression, the de-
tailed mechanism is poorly understood. Our study provides
one possible mechanism underlying this phenomenon.
A number of studies have provided evidence that genotoxic
stimuli such as IR, etoposide and doxorubicin induces the
expression of Fas in a p53-dependent manner [3]. p53 has been
shown to modulate Fas expression with two mechanistically
distinct forms: (a) transactivation of a p53 responsive element
in the Fas promoter and subsequent increased Fas mRNA
synthesis [3], and (b) the traﬃcking of Fas from intracellular
storage vesicles to the cell membrane by a transcription-
independent mechanism [4]. Several studies have demonstrated
that cytoplasmic expression of Fas without surface expression
directly aﬀects the cell resistant to Fas-mediated apoptosis in
pulmonary adenocarcinoma cells including A549 cells [13].
In order to restore cell sensitivity to Fas-mediated apoptosis
in lung cancer cells, it is therefore crucial to elucidate the
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Fig. 4. Eﬀect of p53 inhibitor PFTa on FAP-1 mRNA expression in
irradiated A549 cells. (A) Cells were incubated with or without the
pretreatment of PFTa (50 lM) for 3 h, and exposed to ionizing
radiation (2 Gy). After 3 h, cellular RNA was harvested and analyzed
for FAP-1 mRNA by RT-PCR. (B) The ratio of FAP-1 to GAPDH
mRNA was calculated and expressed relative to that of untreated A549
cells. The values are means ± S.E.M. of three independent experi-
ments. *P < 0.01.
4390 T. Yamada et al. / FEBS Letters 580 (2006) 4387–4391molecular mechanisms responsible for the traﬃcking of Fas to
the cell surface.
FAP-1 expression is frequently observed in a variety of
human tumor cells including lung cancer [14]. It is demon-
strated that FAP-1 expression in cancer cells is related to the
resistance to Fas-mediated apoptosis [15–17]. One of the rea-
sons of this resistance can be due to FAP-1 function that pre-
vents the traﬃcking of Fas from intracellular store to the cell
surface by associating with Fas [7]. A recent report has pro-
vided evidence that FAP-1 is capable of dephospharylating
phosphotyrosine 275 in the C-terminus of Fas in astrocytoma
cells [18]. FAP-1 therefore seems to modulate Fas signaling on
at least two levels: traﬃcking and signal downregulation.
Our results indicate that IR downregulates the expression
of FAP-1 mRNA in A549 cells through the activation of
p53. Mishima and coworkers have shown that a selective
cyclo-oxygenase-2 inhibitor, etodolac, enhances carboplatin-
induced apoptosis of human tongue carcinoma cells by down-
regulation of FAP-1 expression [19]. Based on the ﬁnding
that cyclo-oxygenase-2 has potent inhibitory eﬀects on p53
transcriptional activity [20], etodolac in combination with
carboplatin may inhibit the expression of FAP-1 molecule
through activation of p53. Various other stimuli have been
reported to modulate the expression of FAP-1 in humantumor cells. Song et al. have shown that IL-2 enhances sus-
ceptibility of colon cancer cells to Fas-mediated apoptosis
by upregulating Fas receptor level and downregulating
FAP-1 expression [21]. Mundle and colleagues have demon-
strated that TNF-a decreases the expression of FAP-1
mRNA in HL60 promyelocytic cells [22]. In addition to the
consensus binding sequence for p53, potential binding sites
for a variety of transcription factors including NF-IL-6,
NF-jB, and EWS-FLI1 were found in the 5 0-ﬂanking region
of the human FAP-1 gene [8,23]. The expression of FAP-1
may be regulated by the above agents through either tran-
scription-dependent or transcription-independent mechanism.
In summary, this is the ﬁrst evidence that IR is capable of
modulating FAP-1 mRNA expression via the activation of
p53 pathway in human lung tumor cells. Further studies are re-
quired to better understand the relationship between modula-
tion of FAP-1 and Fas-mediated apoptosis, and its potential
application to lung cancer therapy.
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